Where does Harmony Biosciences Holdings, Inc.'s cash flow data come from?

Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	$145.62M-4.7%	$158.69M+9.1%	$185.68M+51.4%	$180.9M+57.3%	$152.72M+10.9%
Depreciation and amortization	——	——	$26K-93.9%	$26K-95.4%	$111K-80.7%
Stock-based compensation	$43.02M-3.8%	$44.9M+5.4%	$45M+8.7%	$45.07M+17.6%	$44.71M+28.1%
Deferred income taxes	——	——	-$21.39M+5.3%	-$22.34M+9.4%	-$30.13M-107%
Change in accounts receivable	——	——	——	——	——
Change in inventories	——	——	——	$457K—	——
Change in accounts payable	——	——	——	——	——
Change in other assets	-$30.79M—	-$31.79M—	——	——	——
Change in other liabilities	$27.27M+87.1%	$67.99M+476%	$28.12M-6.2%	$24.41M+21.5%	$14.57M-63.7%
Other working capital changes	$1.43M-32.0%	$1.33M-36.5%	$1.41M-33.6%	$1.91M-9.0%	$2.1M+12.5%
Amortization of intangible assets	$23.85M0.0%	$23.85M0.0%	$23.85M0.0%	$23.85M0.0%	$23.85M0.0%
Net cash from operating activities	$341.97M+53.6%	$348.2M+58.4%	$297.61M+34.7%	$259.38M+21.5%	$222.67M+7.1%
Capital expenditures	——	$310K-73.1%	$716K-4.1%	$648K—	$1.28M—
Purchases of investments	$246.01M+148%	$86.15M-18.2%	$103M+12.9%	$102M+1.1%	$99.32M-5.2%
Proceeds from maturities/sales of investments	$86.79M-14.3%	$81.06M-17.7%	$90.51M-0.7%	$94.98M-4.3%	$101.22M+10.9%
Net cash from investing activities	-$225.66M-278%	-$39.65M+41.9%	-$29.2M+69.9%	-$24.41M+75.1%	-$59.68M-17.4%
Repayments of debt	$17.5M+16.7%	$16.25M+8.3%	$15M0.0%	$15M+33.3%	$15M+87.5%
Proceeds from issuance of common stock	$5.85M-47.3%	$10.21M+57.0%	$10.79M+209%	$12.62M+988%	$11.09M+779%
Taxes paid for net share settlement	$4.26M—	$3M—	$4.57M—	——	——
Net cash from financing activities	-$15.92M-106%	-$9.05M+17.7%	-$8.78M+85.8%	-$6.95M+94.0%	-$7.71M+93.1%
Net increase (decrease) in cash	$100.4M—	$299.5M—	$259.63M—	$228.75M—	——
Interest paid	$13.81M-18.4%	$14.69M-15.2%	$15.32M-12.8%	$16.03M-12.4%	$16.93M-13.7%
Accretion (Amortization) of Discounts and Premiums, Investments	$1.29M-39.1%	$1.52M-32.7%	$1.73M-29.5%	$1.95M-25.8%	$2.12M-20.8%
Adjustment For Amortization Of Debt Issuance Costs	$632K-7.9%	$647K-7.6%	$659K-8.0%	$673K-62.4%	$686K-66.3%
Amortization of capitalized software and acquired intangible assets	$23.85M0.0%	$23.85M0.0%	$23.85M0.0%	$23.85M0.0%	$23.85M0.0%
Depreciation	——	——	$26K-93.9%	$26K-95.4%	$111K-80.7%
Depreciation And Impairment Of Long Lived Assets	——	$1.49M+458%	$1.18M+260%	$878.5K+125%	$572.75K+26.6%
In Process Research And Development Acquired	——	——	——	——	——
Accounts payable	——	——	——	——	——
Increase (Decrease) in Prepaid Expense and Other Assets	-$30.79M—	-$31.79M—	——	——	——
Stock Appreciation Rights Market Adjustment	-$198K—	$65K—	——	——	——
Payment Of Upfront Fee Investing Activities	$43.25M+89.1%	$15M-41.2%	$17.63M—	$20.25M—	$22.88M—
Proceeds From Sale And Maturity Of Available For Sale Securities	$86.79M-14.3%	$81.06M-17.7%	$90.51M-0.7%	$94.98M-4.3%	$101.22M+10.9%
Free cash flow	——	$347.89M+59.1%	$296.89M+34.8%	$258.73M+21.6%	$221.39M—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Harmony Biosciences Holdings, Inc.'s cash flow data come from?: Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.